BDBM802306 (S)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl)pyridin-2- yl)-N-(3-fluoro-4-(2- methylmorpholino)phenyl)pyrimidin- 2-amine::US20260109690, Compound I-38

SMILES C[C@H]1CN(c2ccc(Nc3nccc(-c4ccc(-c5nnc(C(F)F)o5)cn4)n3)cc2F)CCO1

InChI Key InChIKey=CRDCLPHDXZXQLR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802306   

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802306BDBM802306((S)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent